DIA: Driving Insights to Action
Science:Life Sciences
In April 2021, the Regulatory Information Management (RIM) Working Group of DIA’s Regulatory Affairs Community issued Version 2.0 of the RIM Whitepaper that provides insights relating to eleven key regulatory capability areas including RIM implementation considerations, processes, and best practices. The Whitepaper also provides context for the RIM Reference Model in development. “One of the key aspects of the model is standardizing terminology and relationships between information,” explains IQVIA Senior Regulatory Affairs Director Donald Palmer in this conversation moderated by Ennov Director of Product Management Kathie Clark. “It puts the stake in the ground in terms of the basic data elements required to support regulatory in its business process and also other functional areas which depend on regulatory,” continues Venkatraman Balasubramanian, Senior Vice President, Life Sciences, Orion Innovation. “If we can put the best practices out there, we all align on the hope that this will allow industry to bring life-saving or life-improving medications and therapies to patients faster. We're hoping to make a big difference,” concludes Pat Shafer, Managing Director, FTI Consulting. Download Version 2.0 of the RIM Whitepaper.
DARWIN EU: Evolution in Europe’s Use of Big Data
Master Protocol Efficiencies Speeding COVID-19 Treatments
Found in Translation: A Tumultuous Year in Review
Biosimilar Awareness, Access and Savings Continue to Grow
R2D2 Aligning Regulatory and HTA Review to Quicken Patient Access
Jump In, Be Brave, Have the Conversation – Reducing Health Disparities among Minority Patients
CTD Speeding Medicines Registration in East Africa
Biosimilar Savings and Their Price: BPCIA Turns Ten
Regulators Promote Reliance as 21st Century Best Practice
Regulatory and Clinical Science Align to Fight COVID-19
DIA Keynote Calls for Expanded COVID-19 Trial Parameters
Impact Philanthropy Accelerating Cures Within Reach
FDA Guidance: Flexibility But No Compromise on Patient Safety
Digital Tools Powering More and Safer Clinical Trials
Latin America's COVID-19 Regulatory Response
Partnerships Essential to SAHPRA Pandemic Response
EFPIA Shares Industry View of EMA Regulatory Framework
Time to Press the Pause Button on Speedy Drug Approvals?
Reach More Patients While Improving Data Quality?
ATMPs May Deliver on Promise of Individualized Medicine
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Stuff To Blow Your Mind
Breakthrough